Strategy for Discontinuation of Anxiolytics in Multidisciplinary Approach

DOI Web Site Web Site 16 References
  • Takaesu Yoshikazu
    Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus
  • Yamada Hisashi
    Department of Neuropsychiatry, Hyogo Medical University
  • Ie Kenya
    Department of General Internal Medicine, St. Marianna University School of Medicine Department of General Internal Medicine, Kawasaki Municipal Tama Hospital
  • Kurosawa Masahiro
    Showa University Karasuyama Hospital Pharmacy
  • Aoki Yumi
    Psychiatric and Mental Health Nursing, Graduate School of Nursing Science, St. Luke’s International University
  • Inada Ken
    Department of Psychiatry, Kitasato University School of Medicine

Bibliographic Information

Other Title
  • 領域・職種を超えて取り組む抗不安薬の出口戦略
  • リョウイキ ・ ショクシュ オ コエテ トリクム コウフアンヤク ノ デグチ センリャク

Search this article

Abstract

<p>Benzodiazepine (BZD) anxiolytics are commonly prescribed for patients with anxiety disorders not only by psychiatrists but also by primary care physicians. Although BZD have been reported to increase the risk of dependence, cognitive decline, and fall, it is difficult to discontinue BZD especially in case with high-dose and/or long-term use the medication due to the development of dependence. Therefore, we developed expert consensus for patients taking long-term and/or high-dose use of BZD. In addition, we also developed training program for disseminating treatment strategy in multidisciplinary approach.</p>

Journal

References(16)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top